Klivira
Request demo

Optimizing Highmark Prior Authorization for Oncology Workflows

Navigating Highmark prior authorization for oncology demands a specialized approach to manage the high volume and clinical complexity inherent in cancer care. Klivira streamlines these critical workflows, ensuring timely approvals for essential treatments.

For revenue cycle directors and prior authorization coordinators managing oncology cases, Highmark's specific requirements, coupled with the rapid evolution of cancer therapies, present significant operational challenges. The need for precise documentation and efficient submission across multiple channels is paramount to minimizing treatment delays and optimizing revenue capture.

Highmark's Prior Authorization Channels for Oncology

Highmark, a prominent BCBS plan serving Pennsylvania, West Virginia, Delaware, and New York, routes most medical-benefit prior authorization submissions for oncology through Availity Essentials. Providers also have the option to submit X12 278 transactions via clearinghouses. For pharmacy-benefit oncology medications, submissions are typically processed through Highmark's pharmacy benefit manager (PBM), which requires verification of the specific PBM relationship at the point of use. Specialized benefit management vendors may also handle specific clinical domains like radiation oncology.

Key Oncology Services Requiring Highmark Prior Authorization

  • High-cost chemotherapy regimens and biologic infusions (HCPCS J-codes)
  • Advanced imaging for staging and surveillance (e.g., PET imaging)
  • Radiation therapy procedures (IMRT, IGRT, SBRT, proton-beam therapy)
  • Specialty oral oncolytics and targeted therapies
  • Genetic and molecular testing for treatment selection and risk stratification

Meeting Highmark's Documentation Standards for Oncology

Highmark's medical policies and utilization management guidelines, accessible via their provider site, frequently align with NCCN Clinical Practice Guidelines and the NCCN Drugs & Biologics Compendium. Essential documentation for oncology prior authorization includes pathology reports with histology, AJCC TNM staging, relevant molecular markers (e.g., ER/PR/HER2, EGFR/ALK/PD-L1), prior-line treatment response, ECOG/Karnofsky performance status, and appropriate compendium citations for off-label drug use. For radiation oncology, specific details like prescribed dose, fractionation, and target volume rationale are required.

Addressing Common Highmark Oncology PA Denials

Oncology prior authorization denials with Highmark often stem from common issues such as off-label use lacking NCCN Compendium support, step therapy requirements for biologics or oral targeted therapies, and documentation gaps (e.g., missing molecular marker results or prior-line treatment details). Site-of-service mismatches (e.g., HOPD vs. freestanding infusion center) and NCD/LCD non-coverage for Medicare Advantage plans are also frequent denial reasons. Effective appeals often necessitate clear clinical rationale and robust documentation.

Klivira's Solution for Highmark Oncology Prior Authorization

Klivira's prior authorization automation platform is engineered to address the unique complexities of Highmark oncology PA. Our system incorporates NCCN-compendium-aware policy logic to guide documentation requirements, facilitates regimen-level PA submissions, and intelligently routes requests based on medical-vs-pharmacy benefit split. We provide concurrent PA tracking for the numerous events across a patient's treatment course and integrate with peer-to-peer scheduling to streamline clinical-necessity reviews, minimizing delays for critical cancer care.

Frequently asked questions

How does Highmark process medical benefit prior authorizations for oncology?

Highmark primarily processes medical benefit oncology prior authorizations through Availity Essentials, their designated provider portal. Providers can also submit X12 278 transactions via their clearinghouse for applicable services. For specific advanced imaging or radiation oncology services, specialized benefit management vendors may be utilized.

What clinical guidelines does Highmark typically follow for oncology PA?

Highmark's utilization management guidelines and medical policies for oncology frequently reference the NCCN Clinical Practice Guidelines and the NCCN Drugs & Biologics Compendium. Adherence to these guidelines, especially for treatment selection and off-label drug use, is crucial for successful prior authorization.

Are oral oncology medications subject to Highmark prior authorization?

Yes, oral oncology medications, which fall under the pharmacy benefit, are typically subject to Highmark prior authorization. These requests are usually routed through Highmark's designated PBM and its electronic prior authorization (ePA) partners, such as CoverMyMeds or Surescripts, requiring a distinct submission pathway from medical benefit drugs.

What are common reasons for Highmark to deny oncology prior authorizations?

Common Highmark oncology PA denial reasons include requests for off-label drug use without sufficient NCCN Compendium support, failure to meet step therapy requirements, documentation deficiencies (e.g., missing pathology or molecular marker results), and site-of-service mismatches. For Medicare Advantage plans, NCD/LCD non-coverage can also lead to denials.

How does Klivira help manage Highmark prior authorizations for complex oncology regimens?

Klivira's platform provides NCCN-compendium-aware logic to streamline documentation gathering, supports regimen-level PA submissions, and ensures correct routing for medical-vs-pharmacy benefit drugs. It also offers concurrent tracking for the high volume of PA events per oncology patient and integrates peer-to-peer scheduling to expedite clinical reviews, reducing administrative burden and treatment delays.

Related coverage

Other highmark prior auth coverage by specialty

Other highmark prior auth workflows

highmark integrations by EMR

Ready to automate this workflow with this payer?

See how Klivira automates prior authorizations for your team.

Request a demo